Evidence map›Paper›PMID 41514438›Full record

ArticleMicrobial cell factories2026

Green metabolic engineering of Synechocystis sp. PCC 6803 for efficient production and sustainable extraction of β-cryptoxanthin and zeaxanthin.

Shanshan Song, Lamya Al Fuhaid, Luca Fortunato, Andreia Farinha, Yu Yang, Geert-Jan Witkamp, Xiongjie Zheng, Salim Al-Babili

Abstract read
In one paragraph

Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shanshan SongThe BioActives Lab, Biological and Environmental Science and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), 23955-6900, Thuwal, Saudi Arabia.
Lamya Al FuhaidBiological and Environmental Science and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), 23955-6900, Thuwal, Saudi Arabia.
Luca FortunatoBiological and Environmental Science and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), 23955-6900, Thuwal, Saudi Arabia.
Andreia FarinhaBiological and Environmental Science and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), 23955-6900, Thuwal, Saudi Arabia.
Yu YangCAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Feng Lin Road 300, 200032, Shanghai, People's Republic of China.
Geert-Jan WitkampBiological and Environmental Science and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), 23955-6900, Thuwal, Saudi Arabia.
Xiongjie ZhengNational Key Laboratory for Germplasm Lnnovation & Utilization of Horticultural Crops, Huazhong Agricultural University, Wuhan, 430070, People's Republic of China.
Salim Al-BabiliThe BioActives Lab, Biological and Environmental Science and Engineering Division (BESE), King Abdullah University of Science and Technology (KAUST), 23955-6900, Thuwal, Saudi Arabia. salim.babili@kaust.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundβ-xanthophylls, such as zeaxanthin and β-cryptoxanthin, display significant bioactive properties including anti-oxidant, anti-inflammation and anti-cancer activities. These properties spur their widespread use in food, animal feed, cosmetic and pharmaceutic sectors. However, commercial carotenoids are dominantly manufactured by chemical synthesis, posing environmental pollution. A minor fraction is sourced from plants and algae, a process often hampered by low yields and high costs. Consequently, microbial biosynthesis has emerged as a promising alternative for producing these high-value compounds.

resultsHere, we engineered the photosynthetic microorganism Synechocystis sp. PCC 6803 for efficient production of zeaxanthin and β-cryptoxanthin by two different strategies. In the first strategy, the gene crtO for echinenone biosynthesis and crtD involved in the myxoxanthophyll biosynthesis were inactivated, which increased the amount of zeaxanthin and β-cryptoxanthin by approximately 30% and 60%, respectively, reaching 1.3 mg/g DCW and 0.15 mg/g DCW in the double mutant ΔcrtO/crtD compared to wild type. The second strategy combined the replacement of the native β-carotene hydroxylase with a heterologous, high-efficiency plant enzyme and further improvement of precursor supply. The final strain oxBDI produced 5 mg/g DCW zeaxanthin and 1.5 mg/g DCW β-cryptoxanthin, fivefold and 18-fold higher than wild type, respectively, representing 80% of the total carotenoids produced. In addition, no significant difference was observed in the growth rate between transgenic strains and wild type under standard lab conditions, suggesting the applicability of this biotechnology strategy. Moreover, we explored the use of natural deep eutectic solvents (NADESs) as a green alternative for β-xanthophylls extraction from the engineered cyanobacteria using a simplified procedure. The NADES composed of food-grade menthol and acetic acid (1:1) achieved the highest efficiency, recovering 3.5 mg/g DCW of zeaxanthin and 1.2 mg/g DCW of β-cryptoxanthin, about 50% higher than the conventional solvent acetone, highlighting the strong potential of NADES as a green and safe solvent for carotenoid recovery from cyanobacteria.

conclusionsTaken together, our work reveals an efficient biotechnological strategy for production of zeaxanthin and β-cryptoxanthin, and a novel and efficient NADES-based method for eco-friendly recovery of high-value carotenoids.

Indexed as

Beta-CryptoxanthinMetabolic EngineeringSynechocystisZeaxanthinsBeta-CryptoxanthinZeaxanthinsCarotenoidCyanobacteriaGreen solventMetabolic engineeringNADESZeaxanthinβ-Cryptoxanthin

Identifiers

PMID41514438
PMCPMC12882227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.